Olfactory bulb in multiple system atrophy

Movement Disorders

Volumn 18, Issue 8, 2003, Pages 938-942

  Kovács, Tibor ^a,b   Papp, Mátyás I ^a   Cairns, Nigel J ^b   Khan, M Nadeem ^c   Lantos, Peter L ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

synuclein; Glial cytoplasmic inclusion; Multiple system atrophy; Olfactory bulb

Indexed keywords

ADULT; AGED; ANOSMIA; ARTICLE; CELL INCLUSION; CELL LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NERVE CELL; OLFACTORY BULB; OLFACTORY NUCLEUS; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SHY DRAGER SYNDROME; SMELLING DISORDER;

AGED; ANTIBODIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEUROGLIA; OLFACTORY BULB; SYNUCLEINS;

EID: 0042975213     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10466     Document Type: Article

References (20)

1. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
2. To PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998;44:415-422.
3. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998;96: 445-452.
4. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-208.
5. Shibuya K, Nagamoto H, Iwabuchi K, Inoue M, Yagishita S, Itoh Y. Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy. J Neurol Sci 2000;17:50-58.
6. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; 55:84-90.
7. Kovács T, Cairns NJ, Lantos PL. β-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in normal ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 1999;25: 481-491.
8. Kovács T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 2001;12:285-288.
9. McShane RH, Nagy Z, Esiri M, King E, Joachim C, Sullivan N, Smith AD. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001;70:739-743.
10. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-287.
11. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:436-446.
12. Müller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002;109:805-811.
13. Nee LE, Scott J, Polinsky RJ. Olfactory dysfunction in the Shy-Drager syndrome. Clin Auton Res 1993;3:281-282.
14. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995;91:247-250.
15. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
16. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992;340:186.
17. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243.
18. Duda JE, Giasson BI, Gur TL, et al. Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 2000;59:830-841.
19. Duda JE, Shah U, Arnold SE, Lee VM-Y, Trojanowski JQ. The expression of α-, β-, and γ-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 1999;160:512-522.
20. ter Laak HJ, Renkawek K, van Workum FPA. The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis Assoc Disord 1994;8:38-48.